3. Sudden cardiac death (SCD) is defined as an unexpected, non-traumatic death due
to cardiac causes occurring in a short time period (generally within 1 hour of
symptom onset) in a person with known or unknown cardiac disease in whom no
previously diagnosed fatal condition is apparent.
Nearly 85% of SCDs occur due to ventricular arrhythmias (either primary VF or brief
ventricular tachycardia degenerating to VF).
5. Treatment
It involves primary prevention (preventing SCD in patients with high-risk conditions),
secondary prevention (preventing SCD in patients revived from SCD) and
cardiopulmonary resuscitation (CPR) in patients presenting cardiac arrest.
Traditional antiarrhythmic agents have either been ineffective in preventing/reducing
sudden death or have increased sudden death and therefore are not recommended.
Beta-blockers, ACE inhibitors and spironolactone may be of some benefit.
Implantable cardiac device (ICD) is the primary treatment modality in most patients.
Radiofrequency ablation for patients with AV bypass tracts, bundle-branch block-
associated VT, arrhythmogenic right ventricular dysplasia-conditions uncommonly seen.